Showing results (921-930 of 2,357) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|August 1, 1990
Modulatory role for CCK-B antagonists in Parkinson's diseaseS Boyce, N M Rupniak, S Tye, et al.Clinical Neuropharmacology|June 1, 1991
Weight gain, increased appetite, and excessive food intake induced by carbamazepineY Lampl, Y Eshel, A Rapaport, et al.Clinical Neuropharmacology|June 1, 1991
Electromyographic guidance of botulinum toxin treatment in cervical dystoniaR M Dubinsky, C S Gray, B Vetere-Overfield, et al.Clinical Neuropharmacology|April 9, 2010
An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteersDavid J Brooks, Spyridon Papapetropoulos, Francois Vandenhende, et al.Clinical Neuropharmacology|January 14, 2012
Paroxetine-associated hypereosinophilia may clinically resemble a panic attackNorio Yasui-Furukori, Yasushi Sato, Hiroyuki Kato, et al.Clinical Neuropharmacology|January 1, 1990
Manipulations of sleep and phototherapy: nonpharmacological alternatives in the treatment of depressionT A WehrClinical Neuropharmacology|October 27, 2011
Medication phobia: a new cause of drug noncompliance in Parkinson diseaseIlana Schlesinger, David RabinowitzClinical Neuropharmacology|March 13, 2012
Actively transported levodopa prodrug XP21279: a study in patients with Parkinson disease who experience motor fluctuationsPeter A Lewitt, Aaron Ellenbogen, Dan Chen, et al.Clinical Neuropharmacology|November 17, 2010
Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosisYara Dadalti Fragoso, Elizabeth Regina Comini Frota, Juarez Silva Lopes, et al.Clinical Neuropharmacology|November 17, 2010
Successful treatment of cerebellar ataxia and tremor in multiple sclerosis with topiramate: a case reportAlexandra Schroeder, Ralf A Linker, Carsten Lukas, et al.Pageof 236